chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase increased, C-reactive protein abnormal, COVID-19, Chest X-ray abnormal, Cough
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge:  PA-C   Admission Date: 10/6/2022 Discharge Date: 10/12/2022  PRESENTING PROBLEM: COVID-19 virus infection [U07.1]   HOSPITAL COURSE BY PROBLEM:   * COVID-19 virus infection Assessment & Plan Patient is a 80 y.o. male with past medical history significant for hepatocellular carcinoma and cirrhosis without ascites, insulin-dependent type 2 diabetes, coronary artery disease, Parkinson's disease, hypertension, hyperlipidemia, obstructive sleep apnea, depression presented with acute hypoxia.  Patient was recently admitted to hospital from September 24th through the 28th for a diagnosis of pneumonia and was treated with levofloxacin and vancomycin for a 5 day course of IV antibiotics.  Patient was discharged to a nursing facility.  Patient tested positive for COVID at his nursing facility on 10/5/2022.  Nursing staff there reported that patient's oxygenation saturations dropped to 70% on room air.  EMS was called and patient was transported to the hospital.  Patient received a nebulizer treatment and 500 mL of fluids per EMS.  Patient was complaining of only cough and denied any other symptoms.    Workup in the ER significant for low oxygen saturations (85% on room air).  Patient was placed on 2 L via nasal cannula with improvement in oxygen saturations to around 95-97% on the 2 L. Labs significant for alk-phos of 428, pro-BNP of 437, normal troponin, normal white blood cell count. UA was unremarkable and showed no acute signs of infection.  Chest x-ray does show his multifocal areas of opacification, but this is improved from his previous admission.  Due to patient having a new diagnosis of COVID 19 virus infection and currently needing supplemental oxygen, he was admitted to the hospital for further evaluation.   As patient requiring supplemental oxygen was started on dexamethasone.  Three days of dexamethasone patient's saturations dexamethasone discontinued.  But due to fluctuating oxygen requirements patient restarted on dexamethasone with plans for discharge to subacute on oral dexamethasone and supplemental oxygen. Currently on 1L only with improving symptoms. CRP downtrend is also reassuring, currently 7.3. he has been vaccinated, but once he is recovered should receive the Bivalent vaccine.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Lung opacity, Oxygen saturation decreased, Pneumonia, Prohormone brain natriuretic peptide increased
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge:  PA-C   Admission Date: 10/6/2022 Discharge Date: 10/12/2022  PRESENTING PROBLEM: COVID-19 virus infection [U07.1]   HOSPITAL COURSE BY PROBLEM:   * COVID-19 virus infection Assessment & Plan Patient is a 80 y.o. male with past medical history significant for hepatocellular carcinoma and cirrhosis without ascites, insulin-dependent type 2 diabetes, coronary artery disease, Parkinson's disease, hypertension, hyperlipidemia, obstructive sleep apnea, depression presented with acute hypoxia.  Patient was recently admitted to hospital from September 24th through the 28th for a diagnosis of pneumonia and was treated with levofloxacin and vancomycin for a 5 day course of IV antibiotics.  Patient was discharged to a nursing facility.  Patient tested positive for COVID at his nursing facility on 10/5/2022.  Nursing staff there reported that patient's oxygenation saturations dropped to 70% on room air.  EMS was called and patient was transported to the hospital.  Patient received a nebulizer treatment and 500 mL of fluids per EMS.  Patient was complaining of only cough and denied any other symptoms.    Workup in the ER significant for low oxygen saturations (85% on room air).  Patient was placed on 2 L via nasal cannula with improvement in oxygen saturations to around 95-97% on the 2 L. Labs significant for alk-phos of 428, pro-BNP of 437, normal troponin, normal white blood cell count. UA was unremarkable and showed no acute signs of infection.  Chest x-ray does show his multifocal areas of opacification, but this is improved from his previous admission.  Due to patient having a new diagnosis of COVID 19 virus infection and currently needing supplemental oxygen, he was admitted to the hospital for further evaluation.   As patient requiring supplemental oxygen was started on dexamethasone.  Three days of dexamethasone patient's saturations dexamethasone discontinued.  But due to fluctuating oxygen requirements patient restarted on dexamethasone with plans for discharge to subacute on oral dexamethasone and supplemental oxygen. Currently on 1L only with improving symptoms. CRP downtrend is also reassuring, currently 7.3. he has been vaccinated, but once he is recovered should receive the Bivalent vaccine.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin normal, Urine analysis normal, White blood cell count normal
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge:  PA-C   Admission Date: 10/6/2022 Discharge Date: 10/12/2022  PRESENTING PROBLEM: COVID-19 virus infection [U07.1]   HOSPITAL COURSE BY PROBLEM:   * COVID-19 virus infection Assessment & Plan Patient is a 80 y.o. male with past medical history significant for hepatocellular carcinoma and cirrhosis without ascites, insulin-dependent type 2 diabetes, coronary artery disease, Parkinson's disease, hypertension, hyperlipidemia, obstructive sleep apnea, depression presented with acute hypoxia.  Patient was recently admitted to hospital from September 24th through the 28th for a diagnosis of pneumonia and was treated with levofloxacin and vancomycin for a 5 day course of IV antibiotics.  Patient was discharged to a nursing facility.  Patient tested positive for COVID at his nursing facility on 10/5/2022.  Nursing staff there reported that patient's oxygenation saturations dropped to 70% on room air.  EMS was called and patient was transported to the hospital.  Patient received a nebulizer treatment and 500 mL of fluids per EMS.  Patient was complaining of only cough and denied any other symptoms.    Workup in the ER significant for low oxygen saturations (85% on room air).  Patient was placed on 2 L via nasal cannula with improvement in oxygen saturations to around 95-97% on the 2 L. Labs significant for alk-phos of 428, pro-BNP of 437, normal troponin, normal white blood cell count. UA was unremarkable and showed no acute signs of infection.  Chest x-ray does show his multifocal areas of opacification, but this is improved from his previous admission.  Due to patient having a new diagnosis of COVID 19 virus infection and currently needing supplemental oxygen, he was admitted to the hospital for further evaluation.   As patient requiring supplemental oxygen was started on dexamethasone.  Three days of dexamethasone patient's saturations dexamethasone discontinued.  But due to fluctuating oxygen requirements patient restarted on dexamethasone with plans for discharge to subacute on oral dexamethasone and supplemental oxygen. Currently on 1L only with improving symptoms. CRP downtrend is also reassuring, currently 7.3. he has been vaccinated, but once he is recovered should receive the Bivalent vaccine.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory distress syndrome, Acute respiratory failure, COVID-19, COVID-19 pneumonia, Endotracheal intubation
Clinical narrative: Patient received Pfizer COVID vaccine on 3/10/21 (lot # EN6208), 4/7/21 (lot # EP7533), and Moderna COVID vaccine on 12/1/21 (lot # 065F21A). Patient was diagnosed with COVID infection on 10/4/22 (symptom onset 9/30/22). On 10/9/22, patient was intubated and admitted to CCU with acute hypoxic respiratory failure secondary to COVID pneumonia, and ARDS. Patient was extubated on 10/11/22 and transferred from CCU to med/surg unit on 10/12/22. As of today (10/18/22), patient is still admitted in the med/surg unit.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer COVID vaccine on 3/10/21 (lot # EN6208), 4/7/21 (lot # EP7533), and Moderna COVID vaccine on 12/1/21 (lot # 065F21A). Patient was diagnosed with COVID infection on 10/4/22 (symptom onset 9/30/22). On 10/9/22, patient was intubated and admitted to CCU with acute hypoxic respiratory failure secondary to COVID pneumonia, and ARDS. Patient was extubated on 10/11/22 and transferred from CCU to med/surg unit on 10/12/22. As of today (10/18/22), patient is still admitted in the med/surg unit.
Age: 69.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Inflammation, Pain in extremity
Clinical narrative: Pt received Prevnar 20 in L arm on 10/11, presented on 10/17 with redness/pain/inflammation in left arm. When contacted on 10/18, reported no worsening, but still experiencing pain
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling in left toe started the night of injection, each day I?ve felt more tingling in lower extremities, most often the left side and some tingling in hands. I have some light tingling in face. The symptoms are better in the morning and feel stronger throughout the day.
Age: 37.0
Sex: M
Vaccine: UNK
Symptoms: Injection site rash, Injection site reaction, Pyrexia, Skin tightness
Clinical narrative: Fever between 100.4 and 102.1 for 24 hrs. Rash and skin tightness surrounding the injection site for 5 days (lessening after day 4).
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: no adverse event. Pt got mono valent Pfizer instead of Bivalent
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Office drew up all vaccines from vial at the beginning of the day and discarded vial. They put the bivalent NDC, lot and expiration on a sticky note and entered all data into the EMR from that sticky note. After a few weeks they realized that some days they had pulled monovalent vial and administered instead of bivalent booster as intended. It is impossible to discern which patient received which vaccine.
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Office drew up all vaccines from vial at the beginning of the day and discarded vial. They put the bivalent NDC, lot and expiration on a sticky note and entered all data into the medical record from that sticky note. After a few weeks they realized that some days they had pulled monovalent vial and administered instead of bivalent booster as intended. It is impossible to discern which patient received which vaccine.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Asymptomatic bacteriuria, COVID-19, Diarrhoea, SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer COVID vaccine on 2/26/21 (lot # EN6198), 3/26/21 (lot # EP6955), and 12/14/21 (lot # FE3594). On 10/10/22, patient admitted to our inpatient med/surg unit with generalized severe weakness, asymptomatic bacteruria, and diarrhea (all secondary to COVID19 infection). Patient was discharged home on 10/12/22.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Office drew up all vaccines from vial at the beginning of the day and discarded vial. They put the bivalent NDC, lot and expiration on a sticky note and entered all data into the database from that sticky note. After a few weeks they realized that some days they had pulled monovalent vial and administered instead of bivalent booster as intended. It is impossible to discern which patient received which vaccine.
Age: 81.0
Sex: M
Vaccine: FLUA4
Symptoms: Chills, Diarrhoea, Tremor
Clinical narrative: Two days after receiving Fluad vaccine, patient experienced violent shaking, chills, and diarrhea.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: NO ADVERSE EVENT. Pt got mono valent Pfizer booster instead of Bivalent Booster
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Office drew up all vaccines from vial at the beginning of the day and discarded vial. They put the bivalent NDC, lot and expiration on a sticky note and entered all data into the EMR from that sticky note. After a few weeks they realized that some days they had pulled monovalent vial and administered instead of bivalent booster as intended. It is impossible to discern which patient received which vaccine.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: NO ADVERSE EVENT. Pt got mono valent Pfizer booster instead of Bivalent Booster
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Office drew up all vaccines from vial at the beginning of the day and discarded vial. They put the bivalent NDC, lot and expiration on a sticky note and entered all data into the EMR from that sticky note. After a few weeks they realized that some days they had pulled monovalent vial and administered instead of bivalent booster as intended. It is impossible to discern which patient received which vaccine.
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chiropractic, Condition aggravated, Impaired work ability, Migraine, Pain
Clinical narrative: I had a migraine from 10/9 to 10/15.  I took iboprofen, imitrex, sklaxin, and flexeril multille times to treat. I saw Dr 2 days in a row for chiropractic adjustments to help alleviate my migraine. The pain never went away until 10/15. My normal migraine are usually 1-2 days and respond to ibuprofen and imitrex. I generally don't need muscle relaxers for my migraines. My worst migraine was only 4 days.  I am not sure if this is related to my COVID vaccine but I did not have any of my known triggers except for stress, but this was better than normal. I missed work for the entire week. I did not see a medical doctor because I felt like a migraine (and I'm a doctor).
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Stress
Clinical narrative: I had a migraine from 10/9 to 10/15.  I took iboprofen, imitrex, sklaxin, and flexeril multille times to treat. I saw Dr 2 days in a row for chiropractic adjustments to help alleviate my migraine. The pain never went away until 10/15. My normal migraine are usually 1-2 days and respond to ibuprofen and imitrex. I generally don't need muscle relaxers for my migraines. My worst migraine was only 4 days.  I am not sure if this is related to my COVID vaccine but I did not have any of my known triggers except for stress, but this was better than normal. I missed work for the entire week. I did not see a medical doctor because I felt like a migraine (and I'm a doctor).
Age: 11.0
Sex: M
Vaccine: FLU4
Symptoms: Dizziness
Clinical narrative: Child said he felt faint, told him to sit for 30 minutes and gave water
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: NO ADVERSE EVENT. Pt got mono valent Pfizer booster instead of Bivalent Booster
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: NO ADVERSE EVENT. Pt got mono valent Pfizer booster instead of Bivalent Booster
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Syringe issue, Underdose
Clinical narrative: the nurse giving the injection, said that most of the vaccine came out between the syringe and the needle. The patient received half than less of the dose. After calling our Clinical Coordinator, we were instructed to re-administer the vaccine.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: NO ADVERSE EVENT. Pt got mono valent Pfizer booster instead of Bivalent Booster
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Fall, Feeling abnormal
Clinical narrative: Writer had 10/6/22 Influenza vaccine visit with Patient and discussed vaccine reactions, Writer unsure if VAERS completed previously.  Day after vaccine 1/23/21 (not within 4 hrs) Patient call nurse triage reporting chills, fever 101.5F, vomiting x 3, stomach pains, diarrhea, headache, myalgias, managed at home but reported "feeling out of it." Patient reported husband had wanted to take her to ER but she declined. Tylenol was advised, started feeling better 5-6 pm 1/24/21, but still had body aches with Tylenol helpful. Then Patient proceeded to have Moderna COVID-19 Vaccine, 2nd primary series, Dose #2 (100 mcg/0.5 ml) Lot 024M20A with no problems. Proceeded to Moderna Covid-19 vaccine booster, dose #3 (50 mcg/0.25 ml) on 11/09/2021 Lot 004F21A missed dialysis day after 11/10/21, also headache and vision changes after vaccine reported. Managed at home, headache improved with Tylenol, had blurry vision before vaccine noted also that eye specialist had attributed to migraines. Patient had fall at home 11/11/21 (2 days after vaccine), did not hit head, husband had to assist up and then mentioned right knee pain but declined knee x-ray, managed at home. Reported a black pinpoint spot in her vision after fall, resolved after nap, advised to continue to follow with eye specialist. Proceeded with Moderna COVID-19 vaccine booster (50 mcg/0.25 ml) Dose #4 on 6/11/2022 Lot 054A22A, not within 4 hours but called nurse triage and reported nausea with vomiting, fever, chills, reported to nurse may not make it to dialysis 6/13/22 (2 days after vaccine) but Writer unable to confirm from chart review if Patient made it to dialysis. Writer confirmed with husband at influenza vaccine visit on 10/6/2022 that patient was "sick" after COVID-19 vaccine dose #1 and after COVID-19 vaccine dose #4.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Migraine, Myalgia, Nausea
Clinical narrative: Writer had 10/6/22 Influenza vaccine visit with Patient and discussed vaccine reactions, Writer unsure if VAERS completed previously.  Day after vaccine 1/23/21 (not within 4 hrs) Patient call nurse triage reporting chills, fever 101.5F, vomiting x 3, stomach pains, diarrhea, headache, myalgias, managed at home but reported "feeling out of it." Patient reported husband had wanted to take her to ER but she declined. Tylenol was advised, started feeling better 5-6 pm 1/24/21, but still had body aches with Tylenol helpful. Then Patient proceeded to have Moderna COVID-19 Vaccine, 2nd primary series, Dose #2 (100 mcg/0.5 ml) Lot 024M20A with no problems. Proceeded to Moderna Covid-19 vaccine booster, dose #3 (50 mcg/0.25 ml) on 11/09/2021 Lot 004F21A missed dialysis day after 11/10/21, also headache and vision changes after vaccine reported. Managed at home, headache improved with Tylenol, had blurry vision before vaccine noted also that eye specialist had attributed to migraines. Patient had fall at home 11/11/21 (2 days after vaccine), did not hit head, husband had to assist up and then mentioned right knee pain but declined knee x-ray, managed at home. Reported a black pinpoint spot in her vision after fall, resolved after nap, advised to continue to follow with eye specialist. Proceeded with Moderna COVID-19 vaccine booster (50 mcg/0.25 ml) Dose #4 on 6/11/2022 Lot 054A22A, not within 4 hours but called nurse triage and reported nausea with vomiting, fever, chills, reported to nurse may not make it to dialysis 6/13/22 (2 days after vaccine) but Writer unable to confirm from chart review if Patient made it to dialysis. Writer confirmed with husband at influenza vaccine visit on 10/6/2022 that patient was "sick" after COVID-19 vaccine dose #1 and after COVID-19 vaccine dose #4.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vision blurred, Visual impairment, Vomiting
Clinical narrative: Writer had 10/6/22 Influenza vaccine visit with Patient and discussed vaccine reactions, Writer unsure if VAERS completed previously.  Day after vaccine 1/23/21 (not within 4 hrs) Patient call nurse triage reporting chills, fever 101.5F, vomiting x 3, stomach pains, diarrhea, headache, myalgias, managed at home but reported "feeling out of it." Patient reported husband had wanted to take her to ER but she declined. Tylenol was advised, started feeling better 5-6 pm 1/24/21, but still had body aches with Tylenol helpful. Then Patient proceeded to have Moderna COVID-19 Vaccine, 2nd primary series, Dose #2 (100 mcg/0.5 ml) Lot 024M20A with no problems. Proceeded to Moderna Covid-19 vaccine booster, dose #3 (50 mcg/0.25 ml) on 11/09/2021 Lot 004F21A missed dialysis day after 11/10/21, also headache and vision changes after vaccine reported. Managed at home, headache improved with Tylenol, had blurry vision before vaccine noted also that eye specialist had attributed to migraines. Patient had fall at home 11/11/21 (2 days after vaccine), did not hit head, husband had to assist up and then mentioned right knee pain but declined knee x-ray, managed at home. Reported a black pinpoint spot in her vision after fall, resolved after nap, advised to continue to follow with eye specialist. Proceeded with Moderna COVID-19 vaccine booster (50 mcg/0.25 ml) Dose #4 on 6/11/2022 Lot 054A22A, not within 4 hours but called nurse triage and reported nausea with vomiting, fever, chills, reported to nurse may not make it to dialysis 6/13/22 (2 days after vaccine) but Writer unable to confirm from chart review if Patient made it to dialysis. Writer confirmed with husband at influenza vaccine visit on 10/6/2022 that patient was "sick" after COVID-19 vaccine dose #1 and after COVID-19 vaccine dose #4.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: PATIENT TESTED + FOR COVID 12-2020  AND EXPIRED 5-2022.  i HAVE NO OTHER INFORMATION.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Full body patches of hives. Roughly 40-50 days ago I had severe poison ivy on my arms. The hives are outlining the exact spot I had poison Ivy in the most interesting manner.  Hives also very prevalent on torso, inner elbows, and legs.  It seems whatever was leftover in my system from the poison ivy has reacted with the vaccine.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Have been losing my hair after about three months from first vaccination. Have now had both Moderna vaccinations & both Moderna boosters. Maybe, lost about 1/3 of my hair. Want to try the Novavax shot, next time, because of this problem.
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen  and painful lymph nodes in left arm pit, no treatment, swelling and pain resolved in two weeks
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Encephalopathy, Intensive care
Clinical narrative: Patient received Pfizer COVID vaccine on 1/21/21 (lot # EL1284), 2/11/21 (lot # EN6201), 11/4/21 (lot # FH8020), and Moderna COVID vaccine on 5/21/22 (lot # 037A22B). Patient resides at a long-term care facility for advanced dementia and was on hospice. On 10/22/22, patient admitted to CCU with high flow nasal cannula for acute hypoxemic respiratory failure due to COVID-19, severe sepsis 2/2 Pneumonia due to COVID-19 virus, and acute encephalopathy. Patient was transferred out from CCU to med/surg unit on 10/13/22. Patient was discharged back to long-term care facility on 10/17/22.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis
Clinical narrative: Patient received Pfizer COVID vaccine on 1/21/21 (lot # EL1284), 2/11/21 (lot # EN6201), 11/4/21 (lot # FH8020), and Moderna COVID vaccine on 5/21/22 (lot # 037A22B). Patient resides at a long-term care facility for advanced dementia and was on hospice. On 10/22/22, patient admitted to CCU with high flow nasal cannula for acute hypoxemic respiratory failure due to COVID-19, severe sepsis 2/2 Pneumonia due to COVID-19 virus, and acute encephalopathy. Patient was transferred out from CCU to med/surg unit on 10/13/22. Patient was discharged back to long-term care facility on 10/17/22.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: patient tested + for covid on    4-24-22 patient passed away on   6-23-22
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: NO ADVERSE EVENT. Pt got mono valent Pfizer booster instead of Bivalent Booster
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: NO ADVERSE EVENT. Pt got mono valent Pfizer booster instead of Bivalent Booster
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Chills, Diarrhoea, Dysgeusia, Fatigue, Headache
Clinical narrative: Fever, Chills, Headache, Diarrhea, Tiredness, Injection Site Pain (minor), Feeling unwell. Tinny taste in my mouth that I still get occasionally.  Reaction began during the night after the shots on Wednesday, October 12th. I woke up with fever and chills, the tin taste in my mouth. Very tired. Ibuprofen helped with the fever. It was gone by the end of day Thursday. I continued to feel tired and draggy with headache, through Saturday. I continued to take Ibuprofen daily which helped. Sunday, October 16th I felt normal again.  I have never had a reaction when taking the flu shot.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Malaise, Pyrexia
Clinical narrative: Fever, Chills, Headache, Diarrhea, Tiredness, Injection Site Pain (minor), Feeling unwell. Tinny taste in my mouth that I still get occasionally.  Reaction began during the night after the shots on Wednesday, October 12th. I woke up with fever and chills, the tin taste in my mouth. Very tired. Ibuprofen helped with the fever. It was gone by the end of day Thursday. I continued to feel tired and draggy with headache, through Saturday. I continued to take Ibuprofen daily which helped. Sunday, October 16th I felt normal again.  I have never had a reaction when taking the flu shot.
Age: 74.0
Sex: F
Vaccine: FLUA4
Symptoms: Arthralgia, Neck pain, Pain, Pain in extremity
Clinical narrative: PATIENT REPORTED TO US TODAY THAT SHE HAD SHARP SHOOTING PAIN IN RIGHT SHOULDER RADIATING UP THE RIGHT SIDE OF HER NECK AND DOWN THE RIGHT ARM UNTIL THE ELBOW, STARTING SOON AFTER THE VACCINE ADMINISTRATION, AND LASTING ALL WEEKEND. THERE DID NOT APPEAR TO BE ANY REDNESS OR SWELLING AT THE INJECTION SITE.  SHE DESCRIBED PAIN AS MODERATE TO SEVERE.  SHE STATES SHE ATTEMPTED TO VISIT URGENT CARE CLINIC,, BUT WAS NOT ABLE TO SEE A DOCTOR (LONG WAIT).   SO SHE SELF TREATED WITH OTC IBUPROFEN, WHICH SEEMED TO HELP WITH GIVING HER REFLIEF FROM THE PAIN.  SHE CALLED HER PCP ON MONDAY WHO TREATED HER FOR PAIN SYMPTOMS.  SHE STATES THE INJECTION SITE WAS HIGHER UP IN THE RIGHT SHOULDER SO SHE THINKS THAT MIGHT BE A POSSIBLE CAUSE FOR THE PAIN.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt got mono valent Pfizer booster instead of Bivalent Booster
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Pt got mono-valent Pfizer booster instead of Bivalent Booster
Age: 23.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect route of product administration
Clinical narrative: Patient was given 0.5mL via IM injection, instead of 0.5mL via SUB-Q injection.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: TESTED + FOR COVID  2-23-22  DECEASED 7-14-22;
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Skin lesion, Swelling
Clinical narrative: Large, raised, irregular,  inflamed lesion.
Age: 47.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Headache, Pruritus
Clinical narrative: PT REPORTED ITCHINESS AND REDNESS ON ARM.  IT LASTED 15 MINUTES.  PT REPORTED HEADACHE THAT LASTED 15 MINUTES.  PT WAS PROVIDED ICE PACK, 1 TABLET OF BENEDRYL, AND 1 WATER BOTTLE TO DRINK.  AFTER 15 MINTUES, PT REPORTED THAT EVERYTHING IS FINE AND SHE WAS READY TO LEAVE.  PT WAS ADVISED TO STAY 30 MINUTES FOR OBSERVATION.  PT DECLINED.  PT ALSO DECLINED FURTHER FOLLOW UP.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acoustic stimulation tests, Tinnitus
Clinical narrative: Bad tinnitus
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt got mono-valent Pfizer booster instead of Bivalent Booster
Age: 101.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: TESTED + FOR COVID 2-22-22 ; DECEASED 3-5-22
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Nausea, Pain in extremity, Pyrexia, Skin warm
Clinical narrative: Patient had sore arm with heat radiating, fever, nausea, but no vomiting or difficulty breathing.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt got mono-valent Pfizer booster instead of Bivalent Booster
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt got mono-valent Pfizer booster instead of Bivalent Booster
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bradykinesia, Confusional state, Fall, Fatigue
Clinical narrative: 7/22/22 urgent urination and incontinence began 7/25/22 headache 7/26/22 headache, slow speech, slow movement 7/27/22 headache, vomited 7/28/22 fell onto back, tired, very weak, mental confusion 7/29/22 too weak to climb stairs, mental confusion; transported and admitted to local hospital with fever of 103, ferritin 75,000, low white blood cells, low platelets. 7/30/22 Diagnosed with hemophagocytic lymphohistiocytosis , treated with 16 mg dexamethasone daily. received platelets, cryoprecipitate. Hospitalized through 8/10/22. Rehab facility through 8/17/22
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Haemophagocytic lymphohistiocytosis, Headache, Micturition urgency, Platelet count decreased, Platelet transfusion
Clinical narrative: 7/22/22 urgent urination and incontinence began 7/25/22 headache 7/26/22 headache, slow speech, slow movement 7/27/22 headache, vomited 7/28/22 fell onto back, tired, very weak, mental confusion 7/29/22 too weak to climb stairs, mental confusion; transported and admitted to local hospital with fever of 103, ferritin 75,000, low white blood cells, low platelets. 7/30/22 Diagnosed with hemophagocytic lymphohistiocytosis , treated with 16 mg dexamethasone daily. received platelets, cryoprecipitate. Hospitalized through 8/10/22. Rehab facility through 8/17/22
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Serum ferritin increased, Slow speech, Urinary incontinence, Vomiting
Clinical narrative: 7/22/22 urgent urination and incontinence began 7/25/22 headache 7/26/22 headache, slow speech, slow movement 7/27/22 headache, vomited 7/28/22 fell onto back, tired, very weak, mental confusion 7/29/22 too weak to climb stairs, mental confusion; transported and admitted to local hospital with fever of 103, ferritin 75,000, low white blood cells, low platelets. 7/30/22 Diagnosed with hemophagocytic lymphohistiocytosis , treated with 16 mg dexamethasone daily. received platelets, cryoprecipitate. Hospitalized through 8/10/22. Rehab facility through 8/17/22
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count decreased
Clinical narrative: 7/22/22 urgent urination and incontinence began 7/25/22 headache 7/26/22 headache, slow speech, slow movement 7/27/22 headache, vomited 7/28/22 fell onto back, tired, very weak, mental confusion 7/29/22 too weak to climb stairs, mental confusion; transported and admitted to local hospital with fever of 103, ferritin 75,000, low white blood cells, low platelets. 7/30/22 Diagnosed with hemophagocytic lymphohistiocytosis , treated with 16 mg dexamethasone daily. received platelets, cryoprecipitate. Hospitalized through 8/10/22. Rehab facility through 8/17/22
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: +  covid 2-17-22;  deceased 3-14-22
Age: 10.0
Sex: F
Vaccine: UNK
Symptoms: Urticaria
Clinical narrative: Has received flu vaccine every year since birth (2012). Hives following 5 days after flu vaccine  in 2021 and 2022.  Resolved after 5 days in 2021. This is day 2 of hives this round, appt scheduled with allergy clinic.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Diplegia, Electrolyte imbalance, General physical health deterioration, Hypoaesthesia
Clinical narrative: Sick, in hospital for RSV December 5,  2021, , kidney stage 3, Lost feeling in feet received flu vaccine approximately December 17, 2021, lost feeling in feet, January 28, 2022, paralyzed waist down on February 1, 2022, diagnosed with Transverse Myelitis, treated 2 weeks, electrolytes unbalanced while in rehab, continued getting worse when he came home on March 12, 2022, back in hospital March 25, everything went crazy.  He died at home March 30, 2022.  Death Certificate , cause of death, Metabolic Encephalopathy, or as a consequence of Transverse Myelitis
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Malaise, Metabolic encephalopathy, Myelitis transverse, Renal disorder
Clinical narrative: Sick, in hospital for RSV December 5,  2021, , kidney stage 3, Lost feeling in feet received flu vaccine approximately December 17, 2021, lost feeling in feet, January 28, 2022, paralyzed waist down on February 1, 2022, diagnosed with Transverse Myelitis, treated 2 weeks, electrolytes unbalanced while in rehab, continued getting worse when he came home on March 12, 2022, back in hospital March 25, everything went crazy.  He died at home March 30, 2022.  Death Certificate , cause of death, Metabolic Encephalopathy, or as a consequence of Transverse Myelitis
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory syncytial virus infection
Clinical narrative: Sick, in hospital for RSV December 5,  2021, , kidney stage 3, Lost feeling in feet received flu vaccine approximately December 17, 2021, lost feeling in feet, January 28, 2022, paralyzed waist down on February 1, 2022, diagnosed with Transverse Myelitis, treated 2 weeks, electrolytes unbalanced while in rehab, continued getting worse when he came home on March 12, 2022, back in hospital March 25, everything went crazy.  He died at home March 30, 2022.  Death Certificate , cause of death, Metabolic Encephalopathy, or as a consequence of Transverse Myelitis
Age: 10.0
Sex: F
Vaccine: UNK
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient's age is 10 and Pfizer vaccine for 12+ was administered
Age: 39.0
Sex: M
Vaccine: FLU4, SMALLMNK
Symptoms: Injection site erythema, Injection site urticaria, Pruritus, Rash papular, Urticaria
Clinical narrative: Woke up on 10/9 with raised hives across both upper arms, elbows, shoulders, and upper back, with some small clusters on both thighs and stomach. Contacted doctor via secure messenger who advised taking an antihistamine and come in if there was no improvement or if the spots began to resemble Monkeypox lesions. Took standard doses of Benadryl tablets to relieve itching every 4 hours. Tapered off to taking Benadryl once a day by 10/14.  Hives were no longer raised by 10/14. Red spots still remain on right arm where hives were the worst cluster, with some faded spots in other places.
Age: 73.0
Sex: F
Vaccine: FLU4
Symptoms: Condition aggravated, Dizziness, Nausea, Parosmia, Seizure
Clinical narrative: Patient had a small seizure within 24 hours after the vaccine was administered.  She has had seizures in the past.  Symptoms included dizziness, nausea, & chemical smell.  These are same symptoms during her seizures.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Balance disorder, Blood test normal, Dehydration, Electrocardiogram normal, Nausea
Clinical narrative: High fever (102°) for 12 hrs. Severe vertigo (spinning and disequilibrium)  w nausea and vomiting for 42 hours. Ended up in ER: treated for dehydration and administered Zofran and meclazine. Still taking 10 mg meclazine 3xs daily.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, Vertigo, Vomiting
Clinical narrative: High fever (102°) for 12 hrs. Severe vertigo (spinning and disequilibrium)  w nausea and vomiting for 42 hours. Ended up in ER: treated for dehydration and administered Zofran and meclazine. Still taking 10 mg meclazine 3xs daily.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: covid + 3-3-22 and deceased 3-16-22.
Age: 61.0
Sex: M
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: PATIENT 61 WAS GIVEN THE HIGH DOSE FLUZONE, PT WAS CONTACTED LATER IN THE EVENING AND FEELS FINE WITH NO SIDE EFFECTS
Age: 60.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19
Clinical narrative: Got Covid Virus after receiving Covid booster
Age: 17.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Dizziness, Pallor, Presyncope
Clinical narrative: Patient c/o dizziness, presyncopal symptoms and paleness.  Patient exhibited s/sx of vasovagal symptoms. 1458: BP 98/64, HR 62 and SPO2 98%; 1503: 92/54, HR 58 and SPO2 98%; BP: 108/72, HR 70 and SPO2 98%
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Received a Moderna booster instead of a Bivalent as indicated.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Received a booster rather than a Bivalent
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Received a booster instead of a Bivalent
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine stored outside of recommended storage temperatures for greater than 2 weeks and administered to patient. Manufacturer contacted. Patient did not experience signs or symptoms of adverse outcome.
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arrhythmia, Condition aggravated
Clinical narrative: cardiac arrhythmia beginning within 1 hour of shot and continuing for 48 hours
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: received a booster dose instead of a Bivalent
Age: 40.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Pain
Clinical narrative: My flu shot was given in the left arm. The vaccine was actually injected above the deltoid and into the shoulder causing now weeks of pain with movement.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine stored outside of recommended storage temperatures for greater than 2 weeks and administered to patient. Manufacturer contacted. Patient did not experience signs or symptoms of adverse outcome.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine stored outside of recommended storage temperatures for greater than 2 weeks and administered to patient. Manufacturer contacted. Patient did not experience signs or symptoms of adverse outcome.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was administered the monovalent vaccine instead of the bivalent booster vaccine.
Age: 95.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fall, Pain, Vomiting
Clinical narrative: Narrative:  Pt reported to RN, evening of vaccine administration having what may be a mechanical fall out of bed, reports he made too big of a movement and slipped on his silk sheets onto the floor. however he did not use the medical alert to call from help. he laid on the ground for 8 hours. a friend came the next morning to assist him. he took his morning meds on an empty stomach and reported vomiting them back up. otherwise pt. reported being sore which improved and overall felling better as of 10/3/22. he declined evaluation but RN and covering PCP plan to visit.
Age: 98.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest X-ray abnormal, Dehydration, Endotracheal intubation, Hypotension, Infection
Clinical narrative: Narrative: Patient was hospitalized on 10/06/22 shortly after receiving the COVID-19 bivalent booster with initial documentation noting pt. feeling unwell after vaccine on 10/04/22 and concern for dehydration. Note indicated that pt. had fever and altered mental status. Further documentation from 10/7/22 by PCP who reviewed outside records indicates that pt. was hypotensive on presentation, had tachypnea, AMS, chest Xray with acute infiltrate in RLL pt. likely with pneumonia. Pt. was intubated with differential: septic shock, sepsis, PNA, UTI, dehydration. If infection, presentation would unlikely be d/t vaccine, but reporting due to timing of vaccine and initial documentation.
Age: 98.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lung infiltration, Malaise, Mental status changes, Pneumonia, Pyrexia
Clinical narrative: Narrative: Patient was hospitalized on 10/06/22 shortly after receiving the COVID-19 bivalent booster with initial documentation noting pt. feeling unwell after vaccine on 10/04/22 and concern for dehydration. Note indicated that pt. had fever and altered mental status. Further documentation from 10/7/22 by PCP who reviewed outside records indicates that pt. was hypotensive on presentation, had tachypnea, AMS, chest Xray with acute infiltrate in RLL pt. likely with pneumonia. Pt. was intubated with differential: septic shock, sepsis, PNA, UTI, dehydration. If infection, presentation would unlikely be d/t vaccine, but reporting due to timing of vaccine and initial documentation.
Age: 98.0
Sex: M
Vaccine: COVID19-2
Symptoms: Sepsis, Septic shock, Tachypnoea, Urinary tract infection
Clinical narrative: Narrative: Patient was hospitalized on 10/06/22 shortly after receiving the COVID-19 bivalent booster with initial documentation noting pt. feeling unwell after vaccine on 10/04/22 and concern for dehydration. Note indicated that pt. had fever and altered mental status. Further documentation from 10/7/22 by PCP who reviewed outside records indicates that pt. was hypotensive on presentation, had tachypnea, AMS, chest Xray with acute infiltrate in RLL pt. likely with pneumonia. Pt. was intubated with differential: septic shock, sepsis, PNA, UTI, dehydration. If infection, presentation would unlikely be d/t vaccine, but reporting due to timing of vaccine and initial documentation.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Injection site rash, Injection site swelling, Urticaria
Clinical narrative: Narrative: Pt received the 2 COVID-19 Moderna vaccines without any reported ADR. However, when administered the 3rd dose/booster, Pt reports experiencing rash and swelling, mostly localized site of injection in right arm/right pectoral muscle. This was reported to PCP 7/5/2022. Pt presented to PCP on 7/2/2022 and reported allergic reaction despite receiving vaccine nearly 3 weeks prior per community documents. He was treated with famotidine, Benadryl, and methylprednisolone in office and was discharged with a Medrol dose pack, triamcinolone cream and famotidine. Urticaria has been persistent and he received prescriptions for loratadine, famotidine, and hydroxyzine by provider per 8/25/2022 community documents. Unclear the exact date and location pt received the vaccine.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Albumin globulin ratio, Anaphylactic reaction, Arthralgia, Cardiac arrest, Chills
Clinical narrative: Narrative: Patient received Pfizer COVID-19 vaccine on 4/12/2022 in community pharmacy. On 6/8/2022, Patient presents to hospital with shooting pain in both knees. While admitted, Patient experienced cardiac arrest due to an anaphylactic reaction precipitated from her immunization, requiring ventilation. She was admitted for 2 weeks, but exact treatment received is not recorded in outside/remote data. Patient is traveling and recently began receiving care at facility. She presented to the ED with fever and chills on 7/4/2022 and reported her history of recent hospitalization. ADR was documented into patient chart. However, Patient left AMA the same day. PMH is significant for asthma and HTN.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Immunisation reaction, Mechanical ventilation, Pain, Pyrexia, White blood cell count increased
Clinical narrative: Narrative: Patient received Pfizer COVID-19 vaccine on 4/12/2022 in community pharmacy. On 6/8/2022, Patient presents to hospital with shooting pain in both knees. While admitted, Patient experienced cardiac arrest due to an anaphylactic reaction precipitated from her immunization, requiring ventilation. She was admitted for 2 weeks, but exact treatment received is not recorded in outside/remote data. Patient is traveling and recently began receiving care at facility. She presented to the ED with fever and chills on 7/4/2022 and reported her history of recent hospitalization. ADR was documented into patient chart. However, Patient left AMA the same day. PMH is significant for asthma and HTN.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:  ED visit only
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Illness, Immune system disorder, Loss of personal independence in daily activities, Myalgia
Clinical narrative: Get really sick from them; muscle aches; fever; Immune system is down; couldn't get out of bed I was too weak; couldn't get out of bed I was too weak; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 67-year-old female patient received BNT162B2 (BNT162B2), on 28Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 67 years for COVID-19 immunisation. The patient's relevant medical history included: "Factor V" (unspecified if ongoing); "COPD" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: BNT162B2 (Dose:2), administration date: Mar2021, for COVID-19 Immunization, reaction(s): "couldn't get out of bed I was too weak", "get really, really sick from them", "my immune system is down", "muscle aches", "fever"; BNT162B2 (Dose:1), administration date: Feb2021, for COVID-19 Immunization, reaction(s): "couldn't get out of bed I was too weak", "get really, really sick from them", "my immune system is down", "muscle aches", "fever". The following information was reported: ILLNESS (non-serious) with onset Oct2021, outcome "unknown", described as "Get really sick from them"; IMMUNE SYSTEM DISORDER (non-serious) with onset Oct2021, outcome "unknown", described as "Immune system is down"; ASTHENIA (non-serious), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) all with onset Oct2021, outcome "unknown" and all described as "couldn't get out of bed I was too weak"; PYREXIA (non-serious) with onset Oct2021, outcome "unknown", described as "fever"; MYALGIA (non-serious) with onset Oct2021, outcome "unknown", described as "muscle aches".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201233151 same patient/drug, different dose and event;US-PFIZER INC-202201233152 same patient/drug/AE, different dose;